Finalist Teams Awarded $1 Million in XPrize Healthspan Contest to Transform Healthy Aging

The XPrize Healthspan—which will split $101 million among teams developing therapeutics to restore muscle, cognitive, and immune function in older adults—has named 10 teams receiving $1 million each.

(XPrize announced the finalists for its XPrize Healthspan competition | XPrize)

The XPrize Healthspan competition has named its top 20 finalist groups that will submit their aging intervention therapies for human trial testing.

Aging &amp; Longevity

Bryan Johnson Edits His Genes To Live Past 120 

Tech mogul Bryan Johnson undergoes follistatin gene therapy to explore its potential for extending human lifespan beyond 120 years.


Peter Attia, M.D., says biohackers misconstrue what it takes to live longer and healthier. 

 Peter Attia (left) and Bryan Johnson (Right). 

Peter Attia calls out rich biohackers like Bryan Johnson for making people think spending money is necessary to live longer. 

Others

Biohackers Convene in Honduras for Unregulated Gene Therapy Trials

Under purported “innovation-friendly” regulation in Próspera, Honduras, the biohacking company Minicircle is conducting trials testing whether their gene therapy technique bolsters muscle building and longevity.

(The city of Próspera on the Honduran island of Roatán | prospera.co)

A startup biohacking company called Minicircle has begun testing gene therapies in far-off Honduras with goals of developing more affordable pro-longevity therapies without FDA oversight.

Search Result: follistatin

10 Finalist Teams Awarded $1 Million in XPrize Healthspan Contest to Transform Healthy Aging

Bryan Johnson Edits His Genes To Live Past 120

An Irritated Peter Attia Calls Out Biohackers Like Bryan Johnson

Biohackers Convene in Honduras for Unregulated Gene Therapy Trials Without FDA Oversight